| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
0.9 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |